Table 4. Significantly enriched immune relevant GO terms in old females and males at Day 180.
Contrast | Sex | GO ID | Description | Category | Genes‡ | padj |
D180 vs. D0 | Female | GO:0045047 | protein targeting to ER | BP | 14 | 5.77E-18 |
GO:0006364 | rRNA processing | BP | 16 | 1.19E-14 | ||
GO:0042788 | polysomal ribosome | CC | 6 | 5.31E-08 | ||
GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane | CC | 4 | 3.08E-06 | ||
GO:0005924 | cell-substrate adherent junction | CC | 6 | 0.049794522 | ||
GO:0003735 | structural constituent of ribosome | MF | 14 | 3.19E-13 | ||
Male | GO:0006612 | protein targeting to membrane | BP | 82 | 7.94E-39 | |
GO:0006119 | oxidative phosphorylation | BP | 58 | 9.48E-27 | ||
GO:0043624 | cellular protein complex disassembly | BP | 54 | 4.69E-13 | ||
GO:0010257 | NADH dehydrogenase complex assembly | BP | 27 | 1.93E-11 | ||
GO:0032981 | mitochondrial respiratory chain complex I assembly | BP | 27 | 1.93E-11 | ||
GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process | BP | 22 | 2.36E-06 | ||
GO:0006521 | regulation of cellular amino acid metabolic process | BP | 17 | 7.53E-05 | ||
GO:0010499 | proteasomal ubiquitin-independent protein catabolic process | BP | 9 | 0.002674681 | ||
GO:1903321 | negative regulation of protein modification by small protein conjugation or removal | BP | 17 | 0.002681796 | ||
GO:0006959 | humoral immune response | BP | 29 | 0.005762827 | ||
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | BP | 17 | 0.006188976 | ||
GO:0045116 | protein neddylation | BP | 6 | 0.031860865 | ||
GO:0050852 | T cell receptor signaling pathway | BP | 29 | 0.036706782 | ||
GO:2001242 | regulation of intrinsic apoptotic signaling pathway | BP | 24 | 0.043430667 | ||
GO:0000502 | proteasome complex | CC | 18 | 5.02E-05 | ||
D180 vs. D28 | Female | GO:0002763 | positive regulation of myeloid leukocyte differentiation | BP | 1 | 0.017610107 |
GO:0038095 | Fc-epsilon receptor signaling pathway | BP | 1 | 0.020494521 | ||
GO:0001047 | core promoter binding | MF | 1 | 0.016815814 | ||
Male | GO:0045047 | protein targeting to ER | BP | 65 | 5.57E-55 | |
GO:0006119 | oxidative phosphorylation | BP | 49 | 5.97E-28 | ||
GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process | BP | 13 | 0.003315273 | ||
GO:0031640 | killing of cells of other organism | BP | 9 | 0.006461521 | ||
GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway | BP | 10 | 0.01646663 | ||
GO:1902750 | negative regulation of cell cycle G2/M phase transition | BP | 14 | 0.032386761 | ||
GO:0097526 | spliceosomal tri-snRNP complex | CC | 9 | 0.00013242 | ||
GO:0005839 | proteasome core complex | CC | 5 | 0.030643822 | ||
GO:0003735 | structural constituent of ribosome | MF | 94 | 1.90E-78 | ||
GO:0140104 | molecular carrier activity | MF | 8 | 0.020074571 | ||
GO:0004298 | threonine-type endopeptidase activity | MF | 5 | 0.048464518 |
Note: ‘‡’ indicated the number of genes enriched in the GO terms.